Finance Director, Revenue

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Revolution Medicines is seeking a Finance Director, Revenue to lead the design, implementation, and management of the company’s Gross-to-Net (GTN) forecasting and accrual infrastructure, product revenue recognition, and government pricing and transparency reporting in support of commercial launch and future growth. This role will function as the company’s subject matter expert on revenue operations, developing scalable processes and governance frameworks, collaborating cross-functionally, and enabling informed decision-making.

The Director will report to the Executive Director, Finance and will play a leadership role in shaping finance readiness as the company transitions into a commercial organization.

• Collaborate with Market Access to define contract terms, and support access strategies with financial and operational integrity.
• Lead the GTN strategy and operational model across commercial products and pipeline assets, working with cross-functional teams to build and scale processes for launch and ongoing commercial operations.
• Establish and maintain robust GTN forecasting and accrual methodologies in partnership with Market Access, Commercial Analytics, and FP&A, with a focus on accuracy, auditability, and cross-functional alignment.
• Provide monthly GTN reporting and insights to executive leadership, including drivers of forecast-to-actual variances and evolving payer or pricing dynamics.
• Oversee all product revenue recognition and reporting, including tracking gross shipments.
• Lead efforts to validate sales discounts and rebates.
• Collaborate with 3PL and Trade & Distribution partners to ensure completeness and accuracy of gross sales data, chargebacks and returns and accounts receivable balances.
• Review financial statements and SEC disclosures related to product revenue, ensuring compliance with SOX and GAAP.

• Serve as functional lead for all U.S. government pricing requirements, including oversight of Medicaid, Medicare Part D, 340B, and VA/FSS programs.
• Manage third-party vendor relationships and ensure compliance with all federal and state price reporting obligations (AMP, BP, URA, SPTR, etc.).
• Monitor evolving regulatory and legislative changes in partnership with Legal and Compliance and advise internal teams on business impacts.

• Design and implement governance frameworks, standard operating procedures (SOPs), and internal control mechanisms to support revenue, and compliance activities.
• Build KPIs and dashboards to track performance, audit readiness, and GTN/GP forecast accuracy.

• Provide strategic direction and mentorship to junior team members (as the function grows), contractors, and external consultants supporting finance and compliance initiatives.
• Serve as a trusted advisor to cross-functional leaders, acting as a bridge between Finance and functions such as Market Access, Trade, and Commercial Strategy.

• Bachelor’s degree in Accounting, Finance, Economics, or a related field.
• Minimum of 12+ years of progressive working experience and a minimum of 6+ years of experience in Product Sales and/or Government compliance roles within the pharmaceutical or biotechnology industry.
• Proven experience leading cross-functional finance work streams tied to product launch readiness and commercial infrastructure.
• Deep understanding of Medicaid, Medicare, 340B, SPTR, AMP, BP, URA, and gross-to-net drivers.
• Demonstrated success implementing finance governance…